SEC Form 4 · accession 0001225208-15-005140
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Donald E Morel Jr.
Officer — Chair of the Board & CEO
Period of report
Feb 17, 2015
Accepted (ET)
Feb 23, 2015 · 1:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 17, 2015 | A | 46,925 | $51.53 | A | 829,187 | D | |
| Common StockF2 | holding | — | — | — | 2,710 | I | By Savings Plan | |
| Common StockF2 | holding | — | — | — | 24,670 | I | Non-Qualified Deferred Compensation Plan |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares represent the portion of the Performance Vesting Restricted Share Awards granted in 2012 that have vested for performance period 11.
- F2Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.